SCHEMBL244699

SCHEMBL244699

CCN(CCCS(=O)(=O)O)c1cc(OC)cc(OC)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.37
LMNA P02545 2/20 0.37
HTT P42858 1/20 0.37
CNR2 P34972 1/20 0.37
ALDH1A1 P00352 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ESR1 P03372 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
GAA P10253 1/20 0.35
MAPK1 P28482 1/20 0.35
GFER P55789 1/20 0.35
MTNR1A P48039 2/20 0.35
MTNR1B P49286 2/20 0.35
POLB P06746 3/20 0.34
TP53 P04637 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
PLA2G2A P14555 1/20 0.34
BLM P54132 1/20 0.34
KMT2A Q03164 2/20 0.33
MAOA P21397 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5526466 0.99 MAPT (0.36) MAPTLMNAHTTCNR2ALDH1A1
SCHEMBL5529306 0.99 MAPT (0.36) MAPTLMNAHTTCNR2ALDH1A1
Water SCHEMBL20853627 0.97 MAPT (0.36) MAPTLMNAHTTCNR2ALDH1A1
SCHEMBL5529309 0.97 MAPT (0.36) MAPTLMNAHTTCNR2ALDH1A1
SCHEMBL241158 0.92 MTNR1A (0.40) ALDH1A1ESR1MTNR1AMTNR1BPOLB
SCHEMBL20853803 0.92 MAPT (0.43) MAPTLMNACNR2ALDH1A1ESR1
SCHEMBL4143235 0.89 MTNR1A (0.39) MAPTLMNAHTTALDH1A1L3MBTL1
SCHEMBL4339833 0.88 MTNR1A (0.42) CNR2ALDH1A1ESR1MTNR1AMTNR1B
SCHEMBL245816 0.86 MTNR1A (0.51) MAPTLMNAHTTESR1SMN1; SMN2
SCHEMBL27516740 0.85 CNR2 (0.50) MAPTCNR2ALDH1A1L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 329 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2319937-B1 BLOOD COMPONENT MEASUREMENT METHOD UTILIZING HEMOLYZED WHOLE BLOOD, AND KIT FOR THE METHOD NIPPON KAYAKU KK (JP) 2016-01-27 EP claimed
US-8883439-B2 Blood component measurement method utilizing hemolyzed whole blood, and kit for the method NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2014-11-11 US claimed
US-20110165608-A1 BLOOD COMPONENT MEASUREMENT METHOD UTILIZING HEMOLYZED WHOLE BLOOD, AND KIT FOR THE METHOD NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-07 US claimed
EP-2319937-A1 BLOOD COMPONENT MEASUREMENT METHOD UTILIZING HEMOLYZED WHOLE BLOOD, AND KIT FOR THE METHOD Nippon Kayaku Kabushiki Kaisha (JP) 2011-05-11 EP claimed
US-20020182600-A1 Method for assaying biological and other constituents using synthetic nucleounits in lateral flow, liquid, and dry chemistry techniques SMITH JACK V (US) 2002-12-05 US claimed
US-5972294-A USED TO MEASURE GLUCOSE CONCENTRATION IN WHOLE BLOOD SAMPLES IN PRESENCE OF OPTICALLY VISIBLE HEMOGLOBIN; COLORIMETRIC MEASUREMENT LIFESCAN, INC. (US) 1999-10-26 US claimed
US-4877727-A Substrate for determining leucine aminopeptidase or gamma-glutamyltranspeptase activity KYOWA MEDEX CO., LTD. (JP) 1989-10-31 US claimed
US-12498366-B2 Measurement method for fibroblast growth factor-23 by forming immunocomplexes CANON MEDICAL DIAGNOSTICS CORPORATION (JP) 2025-12-16 US disclosed
EP-3995586-B1 GLYCOSYLATED PROTEIN ASSAY REAGENT CONTAINING PROTEASE STABILIZER INCREASING REDOX POTENTIAL OF FERROCYANIDE, METHOD FOR ASSAYING GLYCOSYLATED PROTEIN, METHOD FOR PRESERVING GLYCOSYLATED PROTEIN ASSAY REAGENT, AND METHOD FOR STABILIZING GLYCOSYLATED PROTEIN ASSAY REAGENT NAGASE DIAGNOSTICS CO LTD (JP) 2025-11-05 EP disclosed
US-20250115944-A1 METHOD FOR MEASURING L-ASPARAGINE AND KIT FOR THE SAME ENZYME-SENSOR Co., Ltd. (JP) 2025-04-10 US disclosed
US-12264356-B2 Method for determining sensitivity to SGLT2 inhibitor and sensitivity marker for SGLT2 inhibitor NIHON UNIVERSITY (JP) 2025-04-01 US disclosed
US-12168795-B2 Method for measuring cholesterol in low-density lipoprotein, measurement reagent, and measurement kit HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD. (JP) 2024-12-17 US disclosed
US-20240402163-A1 Method for Measuring Fibroblast Growth Factor-23 and Reagent Therefor HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD. (JP) 2024-12-05 US disclosed
US-5334507-A Pyruvate kinase, glycerol kinase, glycerol-3-phosphate oxidase, peroxidase, reduced chromogen, adenosine diphosphate, phosphoenolpyruvic acid TOYO BOSEKI KABUSHIKI KAISHA (JP) 1994-08-02 US disclosed
EP-0533183-A2 Composition for the measurement of potassium ion concentration TOYO BOSEKI KABUSHIKI KAISHA Trading under the name of Toyobo Co., Ltd. (JP) 1993-03-24 EP disclosed
EP-0152274-B1 METHOD FOR THE DETERMINATION OF LEUCINE AMINOPEPTIDASE (LAP) Kyowa Medex Co. Ltd. (JP) 1993-01-20 EP disclosed
US-4877727-A Substrate for determining leucine aminopeptidase or gamma-glutamyltranspeptase activity KYOWA MEDEX CO., LTD. (JP) 1989-10-31 US disclosed
US-4778757-A ADDING FIRST REAGENT OF OXIDASE, PEROXIDASE AND PHENOLIC CHROMOGEN FOLLOWED BY ADDING COUPLER; ACCURATE COLORIMETRY TOYO BOSEKI KABUSHIKI KAISHA (JP) 1988-10-18 US disclosed
EP-0243901-A1 Process and reagent for the detection of heart lesions or heart diseases Roche Diagnostics GmbH (DE) 1987-11-04 EP disclosed
EP-0152274-A2 Method for the determination of Leucine Aminopeptidase (LAP) Kyowa Medex Co. Ltd. (JP) 1985-08-21 EP disclosed